Tramadol Hydrochloride
Product Images NDC 61919-002

4 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 61919-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (,odule2)

Image Description (,odule2)
A line graph titled 'Tramadol ER Tablets Study 023 WOMAC Pain Responder Analysis' showing the percentage of patients achieving various levels of pain improvement from baseline. The graph compares different doses of Tramadol ER (100 mg, 200 mg, 300 mg, 400 mg) and placebo across increasing response thresholds expressed as percent improvement.*
FDA Label Image

Image Description (Label 2)

Image Description (Label 2)
Label for TRAMADOL HCl ER C-IV 150 mg extended-release capsules, 30 count, distributed by DIRECT RX, Alpharetta, GA. The label includes dosage form and strength, cautionary notes, storage instructions, lot number, expiration date (08/17), and warnings about potential side effects. The NDC 61919-002 is displayed.*
FDA Label Image

Image Description (Module1)

Image Description (Module1)
Chemical structure of Tramadol Hydrochloride showing its molecular formula C16H25NO2·HCl with labeled functional groups and chemical bonds.*
FDA Label Image

Image Description (Module3)

Image Description (Module3)
A line graph titled 'Tramadol ER Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis,' comparing the percent of patients achieving response thresholds between Tramadol ER and placebo groups. The x-axis represents response threshold as percent improvement from baseline, and the y-axis shows the percent of patients responding. Two lines depict outcomes for Tramadol ER and placebo over varying response thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.